Secretagogues drugs

Comments: When used in combination with an insulin secretagogue (e.g. sulfonylurea) or insulin, a lower dose of the insulin secretagogue or insulin may be

Drug Interactions. When initiating RYBELSUS, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or

Hypoglycemia: When RYBELSUS is used with an insulin secretagogue or insulin, consider lowering the dose of the secretagogue or insulin to reduce the risk of

secretagogues (e.g, sulfonylureas) or insulin to reduce the risk of hypoglycemia. drugs, over-the-counter drugs, and herbal preparations, have not

medicines (pills), insulin, and/or other injected medicines Insulin Secretagogues. Insulin secretagogues are one type of medicine

If hypoglycemia occurs in a patient coadministered DUETACT and an insulin secretagogue, the dose of the insulin secretagogue should be reduced.

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. Authors Cross-References.

secretagogues (sulfonylureas, meglitinides). The term factitious In addition to patients who knowingly take insulin secretagogue drugs

Secretagogues are classified as sulfonylureas or non-sulfonylureas (repaglinide). The primary action of secretagogues is to increase the release of insulin